Advertisement

Loading...

Genscript Biotech Corporation

1548.HKHKSE
Healthcare
Biotechnology
HK$12.10
HK$1.15(10.50%)
Hong Kong Market is Open • 10:06

Genscript Biotech Corporation (1548.HK) Stock Competitors & Peer Comparison

See (1548.HK) competitors and their performances in Stock Market.

Peer Comparison Table: Biotechnology Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
1548.HKHK$11.77+7.00%23.9B-5.70-HK$1.92N/A
6160.HKHK$184.10+7.60%257.8B115.17HK$1.49N/A
1801.HKHK$90.65+5.28%146.1B160.19HK$0.53N/A
2269.HKHK$34.94+11.42%136.5B25.21HK$1.31N/A
9926.HKHK$139.50+4.81%119.8B-119.45-HK$1.09N/A
1177.HKHK$6.34+8.38%105.3B39.27HK$0.15+1.53%
1530.HKHK$25.16+3.62%53.4B20.77HK$1.09+1.10%
9995.HKHK$109.90+11.18%52.7B65.62HK$1.46N/A
3759.HKHK$20.82+13.96%51.4B19.40HK$0.97+1.16%
2696.HKHK$75.60+8.54%37.9B40.79HK$1.71N/A
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

1548.HK vs 6160.HK Comparison April 2026

1548.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 1548.HK stands at 23.9B. In comparison, 6160.HK has a market cap of 257.8B. Regarding current trading prices, 1548.HK is priced at HK$11.77, while 6160.HK trades at HK$184.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

1548.HK currently has a P/E ratio of -5.70, whereas 6160.HK's P/E ratio is 115.17. In terms of profitability, 1548.HK's ROE is -0.13%, compared to 6160.HK's ROE of +0.07%. Regarding short-term risk, 1548.HK is more volatile compared to 6160.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 1548.HK.Check 6160.HK's competition here

Stock price comparison of stocks in the Healthcare Sector

Loading...

Frequently Asked Questions